Early detection of cancer can be the next best thing to prevention. There are several widely known risk factors for prostate cancer that may increase the probability of a man to develop prostate cancer. Age, race and family history are the most common today. According to ASCO Cancer.Net, “Prostate cancer that runs in a family, called familial prostate cancer, occurs about 20% of the time.” Sources say that shared genes, similar lifestyles and environments play a role in developing familial prostate cancer. Hereditary prostate cancer accounts for almost 5% of cases. This type of gene mutation is passed down within family generations. A few characteristics for hereditary prostate cancer could include: Read More
At Provision CARES Proton Therapy, we are dedicated to providing a safe workplace for our employees and a safe treatment environment for our patients. Just this month, our Provision CARES Cancer Center team in Knoxville received the official Accreditation Certificate issued by ASTRO (“Accreditation Certificate”). To receive this accreditation, the team was required to focus on five pillars of patient care. One of the five pillars of patient care is safety. The team demonstrated and committed to the highest standards of safety through daily processes and procedures. To read more about the Accreditation process and this achievement see our previous blog here. Read More
Proton therapy got positive billing at the recent Particle Therapy Cooperative Group, as researchers from across the country presented findings that showed proton therapy reduced potentially life-altering side effects and improved survival rates for cancer patients.
Thousands of cancer patients have and could benefit from proton therapy, and children definitely top the list.
This week, exciting news has emerged from the renowned Children’s Hospital of Philadelphia confirming that proton therapy effectively treats pediatric cancers of the head and neck and reduces the side effects often experience with conventional radiation treatment.
It’s one more step toward growing and full recognition of proton therapy in the medical community as a state-of-the-art treatment option for cancer. Read More
They have come from as close as down the road and as far away as China. Their cases have ranged from highly curable to palliative care. They light up lobby with laugher and courage. And they most clearly show cancer for the monstrosity it is.
September is Pediatric Cancer Awareness Month. Read More
This year Eddie Check is doing the same thing it’s been doing for the past 14 years: providing prostate cancer screenings and blood donations to the people of East Tennessee.
This year’s event kicks off Thursday, Sept. 14, and will be hosted at 12 sites throughout the Knoxville region on Thursday and Friday. The event offers free PSA screenings to men over 40 years old—blood donations encouraged but not required. Read More
That included treatment for prostate cancer.
Raffleld started out with a B.S. in physics and a career in the Air Force where he planned and evaluated instructional systems for the military’s intercontinental ballistic missiles program during the Vietnam War. He became a captain, serving as combat crew commander and wing instructor and discovered he enjoyed “arranging resources to accomplish the mission,” he said. “At the time, I didn’t know what that was called, but in business, that’s operations.”
After his military career ended, Raffield didn’t settle into the field he had chosen but embarked in a new direction, starting out as a territory sales manager for Michelin Tire and ending up management and operations for Truckstops of America and Universal Tire.
“I tended to say, ‘I’m going to do what fits me,” he said. Read More
When it comes to prostate cancer treatment, there’s bad news and there’s good news.
The bad news: Prostate cancer ranks the third most common cancer in the U.S. Healthcare providers diagnose more than 200,000 new cases each year. Approximately 14 percent of men will succumb to prostate cancer in their lifetimes. The good news: Most diagnosed with prostate cancer survive. The disease represents 13.3 percent of all new cancer cases. But only 4.7 percent of those diagnosed will die of the disease. Research shows five-year relative survival rates for prostate cancer at 99.7 percent. (National Cancer Institute)
How long cancer patients survive following treatment can be influenced by one simple factor: sleep. Research reveals that breast cancer patients who sleep less at night and snore frequently have poorer survival rates than those with longer, better quality sleep. Read More